Sign inJoin waitlistJoin the waitlist

Corey Langer

Chair | Hematology Oncology · University of Pennsylvania Health System

Credentials: · · · · · ·

History

University of Pennsylvania Health System
Present
Abramson Cancer Center · University of Pennsylvania Health System
Present
University of Pennsylvania Health System
Present

Presbyterian Medical Center
1987–1989
Hematology and Medical Oncology
Fox Chase Cancer Center
1984–1987
Internal Medicine
1981–1984
Boston University School of Medicine
1977–1981

Research

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
New England Journal of Medicine · 2002 · 4,381 citations
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
Review · Seminars in Radiation Oncology · 2003 · 2,252 citations
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic…
Journal of Clinical Oncology · 2004 · 1,584 citations

RC
Roger Cohen
71 papers
Charu Aggarwal
69 papers
Benjamin Movsas
45 papers · 1 as a resident
Melina Marmarelis
38 papers · 2 as a fellow
Joshua Bauml
33 papers · 6 as a fellow
Aditi Singh
32 papers · 9 as a fellow
TE
Tracey Evans
32 papers
Christine Ciunci
28 papers
LS
Lova Sun
27 papers · 3 as a fellow
Steven Feigenberg
24 papers · 5 as a resident
Jeff Bradley
20 papers
Keith Cengel
20 papers

Clinical trials

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Principal investigator · Recruiting · Phase 1
Abramson Cancer Center at Penn Medicine
2023–2027
Predictive Assay for Decision Making in Adjuvant Therapy
Principal investigator · Terminated
Insight Molecular Diagnostics
2022
Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer
Principal investigator · Terminated · Phase 2
University of Pennsylvania
2018–2021
Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer
Principal investigator · Completed · Phase 2
Abramson Cancer Center at Penn Medicine
2015–2022